Q1 2020 FLY Leasing Ltd Earnings Call
DALLAS and FORT WORTH, Texas, Aug. 29, 2019 -- Neos Therapeutics, Inc. (Nasdaq: NEOS), a commercial-stage pharmaceutical company utilizing its novel microparticle delivery.
DALLAS and FORT WORTH, Texas, Nov. 08, 2019 -- Neos Therapeutics, Inc. (Nasdaq: NEOS), a commercial-stage pharmaceutical company utilizing its novel microparticle delivery.
There's been a major selloff in Neos Therapeutics, Inc. (NASDAQ:NEOS) shares in the week since it released its yearly...
DALLAS and FORT WORTH, Texas, Sept. 25, 2019 -- Neos Therapeutics, Inc. (Nasdaq: NEOS), a commercial-stage pharmaceutical company utilizing its novel microparticle delivery.
I’m going to do the most “man” thing I can possibly do in this situation. The post 10 Things Books — Okay, the Internet — Didn’t Tell Me About Becoming a Dad appeared first on The Good Men Project.
If you're interested in Neos Therapeutics, Inc. (NASDAQ:NEOS), then you might want to consider its beta (a measure of...
AZUL earnings call for the period ending March 31, 2020.
Return of stranded mariners gathers pace as govt. lets cruiseliners hire flights
DALLAS and FORT WORTH, Texas, Nov. 01, 2019 -- Neos Therapeutics, Inc. (Nasdaq: NEOS), a commercial-stage pharmaceutical company utilizing its novel microparticle delivery.
Neos Therapeutics, Inc. (NEOS), a commercial-stage pharmaceutical company developing and manufacturing central nervous system-focused products, today announced that it has initiated and completed dosing in a Phase 1 pilot pharmacokinetic study evaluating the safety and tolerability of NT0502 in healthy volunteers. NT0502 is a new chemical entity and selective anticholinergic agent that, based on preclinical data, is preferential for blocking muscarinic receptors in the salivary glands. The Company is developing NT0502 for the treatment of chronic sialorrhea, which is defined as prevalent and excessive drooling from the mouth resulting from the inability to control and swallow oral secretions, a common problem in patients with a variety of debilitating neurological conditions.
DALLAS and FORT WORTH, Texas, May 04, 2020 -- Neos Therapeutics, Inc. (Nasdaq: NEOS), a commercial-stage pharmaceutical company developing and manufacturing central nervous.
Q3 2019 Neos Therapeutics Inc Earnings Call
As an investor, mistakes are inevitable. But really big losses can really drag down an overall portfolio. So spare a...
Return of stranded mariners gathers pace as govt. lets cruiseliners hire flights
DALLAS and FORT WORTH, Texas, May 26, 2020 -- Neos Therapeutics, Inc. (Nasdaq: NEOS), a commercial-stage pharmaceutical company developing and manufacturing central nervous.
DALLAS and FORT WORTH, Texas, March 30, 2020 -- Jerry McLaughlin, President and CEO, made the following statement: We want to share the steps we are taking to ensure.
Austria's Economy Ministry confirmed on Friday it had removed a database from its website that for years showed the home addresses of around a million people including the president and cabinet ministers, but it denied there had been a data leak.
In a regulatory filing, it was disclosed that J.C. Penny CEO Jill Soltau received a $4.5 million bonus. Three top executives, including the chief financial officer Bill Wafford, chief merchant officer Michelle Wlazlo and chief human resources officer Brynn Ev…
DALLAS and FORT WORTH, Texas, March 06, 2020 -- Neos Therapeutics, Inc. (Nasdaq: NEOS), a commercial-stage pharmaceutical company developing and manufacturing central nervous.
DALLAS and FORT WORTH, Texas, April 09, 2020 -- Neos Therapeutics, Inc. (NASDAQ: NEOS), a commercial-stage pharmaceutical company developing and manufacturing central nervous.
The first quarter was a breeze as Powell pivoted, and China seemed eager to reach a deal with Trump. Both the S&P 500 and Russell 2000 delivered very strong gains as a result, with the Russell 2000, which is composed of smaller companies, outperforming the large-cap stocks slightly during the first quarter. Unfortunately sentiment shifted […]
WarnerMedia's platform is officially entering the streaming wars
Hollywood, and the media industry had an enthralling 2019: Viacom and CBS re-merged, Disney bought a chunk of Fox, everyone and their second cousin’s favorite uncle launched, or solidified plans for, a streaming service, and the executives at the top of the h…
Austria's Economy Ministry confirmed on Friday it had removed a database from its website that for years showed the home addresses of around a million pe...
Q4 2019 Neos Therapeutics Inc Earnings Call
Supported by A lot of gear comes across our desks here at CyclingTips. Our Tech Round-Up is a look at some of that gear. Sometimes it’s products we’re doing long-term tests on, other times it’s stuff we’re stoked on but don’t have time to fully re…
– Full year 2019 net revenues increased by 29% and operating loss decreased by $33M – – Neos RxConnect rapidly expanded with ~500 pharmacies in network at year-end –.
This study aims to evaluate the commercial aircraft fleet and spending on MRO services among the top 3 Northeast Asian nations consisting of China, South Korea, and Japan boasting a combined airline fleet size of close to 5,000 aircraft at the end of 2019. Th…
Chris Anderson opens his 2012 book, Makers, with a story about his maternal grandfather, Fred Hauser. Anderson recalls a childhood experience spending a summer with his grandfather at his bungalow in the Westwood neighborhood of Los Angeles. “He announced tha…
DALLAS and FORT WORTH, Texas, Feb. 26, 2020 -- Neos Therapeutics, Inc. (Nasdaq: NEOS), a commercial-stage pharmaceutical company developing and manufacturing central nervous.
Q1 2020 Neos Therapeutics Inc Earnings Call
Amid the fallout from COVID-19, a broad range of sectors have felt the effects on the compensation of their executives and boards. In addition to hard-hit industries such as hospitality, retail, and aerospace, many health care companies and IT firms have been…
– Company announces reduction in force to streamline costs and accelerate the path to profitability, particularly in light of the business impact from the COVID-19 pandemic – –.
AMC Networks president and CEO Josh Sapan’s pay dipped to $20.2 million in 2019, which is down just under 2% from what he made in 2018, the company revealed via a regulatory filing Wednesday. The overseer of AMC, Sundance TV, IFC, BBC America, WE TV and all t…
FLY earnings call for the period ending May 10, 2020.
The smid-cap biotech earnings deluge hit Wall Street in the week ended May 9, positively impacting the stocks in the sector. The iShares NASDAQ Biotechnology Index (NASDAQ: IBB) gained about 6% for the week.Large-cap pharma names AstraZeneca plc (NYSE: AZN) a…